The long term investment performance of our model equity portfolios continues to be solid.
Part 1: Australian Equities
Our Australian Equity model portfolio returned 10.21% over the year ending 30 June 2018 (2.80% below the market index).
Strong contributions came from Nextdc (+75%), BHP (+57%), Rio Tinto (+43%), CSL (+38%), Seek (+33%) and Wesfarmers (+32%).
Conversely, Telstra (-31%), Ramsay Healthcare (-23%), Integrated Research (-21%) and Challenger (-14%) detracted from performance.
Over the last 10 years, the model portfolio has outperformed the ASX200 Accumulation Index by 46%.
Integrated Research was removed due to management concerns following a disappointing profit downgrade only weeks after advising the market that there were no material issues to disclose.
Challenger was removed to reduce financial services exposure.
Cochlear was removed on valuation grounds (great company but overvalued in the short run).
Nextdc was removed on valuation grounds (share price well above our intrinsic valuation).
Boral included due to positive outlook for non-residential construction in Australia and favourable residential construction outlook in the United States.
Chorus (CNU) included as fundamentals are appealing. CNUs is the leading telecommunication company in New Zealand and will own 81% of the fibre network once the rollout is complete. We estimate cashflow could be in the order of 60c/share post-rollout, which would make it an attractive proposition at current prices.
Part 2: Direct International Equities
Due to the success of our Australian equity model portfolios, we began managing our own direct international equity portfolios in 2016. These were initially rolled out to a selective group of high net wealth clients who had expressed interest in these services. As the pilot period has been successful, these portfolios are now available to most non-platform clients. An update follows.
Our International Equity model portfolio returned 23.39% over the year ending 30 June 2018 (11.60% above the market index).
Strong contributions came from Apple (+35%), Adobe (+77%), Microsoft (+51%) and Royal Dutch Shell (+48%).
British American Tobacco (-21%), Zimmer (-5%), Nestle (-4%) and Johnson & Johnson (-3%) detracted from performance.
Zimmer and Harley Davidson were sold during the year and replaced with Abbot Laboratories and Alibaba Group.
Monsanto was subject to a takeover offer by Bayer where we elected to take the cash proceeds.
Since inception, the model portfolio has outperformed the MSCI World (ex-Australia) (Local currency) Index by 17%.
Monsanto due to takeover by Bayer.
 Disclaimer: Past performance is not a reliable indicator of future performance.